Sign in
CompletedNo phase

Point of Care Evaluation of Fibrinolysis in Sepsis

Key facts

Who runs it
Policlinico Hospital
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
100 people enrolled
Started
22 Jan 2024
Ended
30 Nov 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Clot Pro
Record updated
8 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • age > 18 years
  • sepsis or septic shock
  • vasopressors required to maintain a MAP ≥ 65 mmHg despite adequate fluid resuscitation

Who cannot take part

  • ECMO therapy
  • use of oral anticoagulant drugs
  • coagulation disorders

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Impaired fibrinolysis in septic patients is associated with worse outcome. The present study investigates fibrinolysis shutdown in septic patients, defined as prolonged ClotPro® TPA lysis time at 30 minutes. The TPA lysis time reference range is established in a cohort of healthy volunteers.

The 2 groups in the trial

  • Septic patientsOther group

    Treatment: Clot Pro

  • Healthy volunteersOther group

    Treatment: Clot Pro

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
8 April 2026